Literature DB >> 31201049

Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?

James D Triplett1, Nicholas D Lawn2, Josephine Chan3, John W Dunne4.   

Abstract

Metabolic encephalopathy and Non-Convulsive Status Epilepticus (NCSE) have been reported with cephalosporin use, particularly cefepime. We aimed to analyze the clinical and EEG findings in patients with cephalosporin-related neurotoxicity (CRN) at our hospital identified via the hospital EEG database, and to critically review CRN case reports in the literature. A Medline search was performed to identify CRN cases where a representative sample of EEG was provided. EEGs were analyzed using published criteria differentiating NCSE from triphasic waves (TW). Eleven patients at our hospital were identified with CRN (9 cefepime, 2 ceftriaxone): all had an encephalopathy with decreased consciousness and/or confusion. One patient had clinical seizures and 6 had multifocal myoclonus. All patients had abnormal EEGs, all with moderate to severe generalized slowing and 10 also with TW. Recovery was related to cephalosporin withdrawal rather than antiepileptic therapy. Analysis of 37 EEG samples of CRN patients reported in the literature as NCSE (30) or TW (7) revealed that most did not meet criteria for NCSE, with 33 showing TW, 1 showing generalised epileptiform discharges and 3 being uninterpretable. CRN usually produces a toxic encephalopathy rather than NCSE, and is commonly associated with triphasic waves on EEG. In most patients anti-epileptic and/or sedative drugs do not hasten clinical improvement.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31201049     DOI: 10.1016/j.jocn.2019.05.035

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Infectious stress triggers a POLG-related mitochondrial disease.

Authors:  Paula Gaudó; Sonia Emperador; Nuria Garrido-Pérez; Eduardo Ruiz-Pesini; Delia Yubero; Angels García-Cazorla; Rafael Artuch; Julio Montoya; María Pilar Bayona-Bafaluy
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

2.  Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?

Authors:  Yayoi Kawano; Olivier Jordan; Takehisa Hanawa; Gerrit Borchard; Viorica Patrulea
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-05-19       Impact factor: 4.730

3.  Cefepime-Induced Neurotoxicity in the Setting of Acute Kidney Injury: A Case Series and Discussion of Preventive Measures.

Authors:  Severin Bausch; Laura J Araschmid; Martin Hardmeier; Michael Osthoff
Journal:  Cureus       Date:  2022-06-28

4.  Ceftriaxone-induced encephalopathy in a patient with multicentric glioma.

Authors:  Mariette Anto; Rajesh Shankar Iyer; Adarsh Manuel; Akarsh Jayachandran; Rosmy Jose; Nisha John; Puja Shyam; Anjitha Thankachan; Santhosh George Thomas; Biji Bahuleyan
Journal:  Surg Neurol Int       Date:  2022-07-15

5.  Description of neurotoxicity in a series of patients treated with CAR T-cell therapy.

Authors:  Catherine Belin; Perrine Devic; Xavier Ayrignac; Amélie Dos Santos; Adrien Paix; Lila Sirven-Villaros; Claire Simard; Sylvain Lamure; Thomas Gastinne; Renata Ursu; Colette Berger; Laura Platon; Benoît Tessoulin; Elie Azoulay; Florent Wallet; Catherine Thieblemont; Emmanuel Bachy; Guillaume Cartron; David A Laplaud; Antoine F Carpentier
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

6.  Serious Neurological Adverse Events of Ceftriaxone.

Authors:  Clémence Lacroix; Annie-Pierre Bera-Jonville; François Montastruc; Lionel Velly; Joëlle Micallef; Romain Guilhaumou
Journal:  Antibiotics (Basel)       Date:  2021-05-06

7.  Cefepime-Induced Neurotoxicity in a 74-Year-Old Woman.

Authors:  Samanvaya Sharma; Muzammil Khan; Muhammad Owais; Asim Haider
Journal:  Cureus       Date:  2022-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.